ELTP.US Elite Pharma Inc

Healthcare Pharmaceuticals USA Stocks
0.3200 USD
Close of Nov 14, 2026
0.2100 0.6400
Market cap
USD 345M
P/E
8.0x
P/B
2.52x
ROE
22.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is ELTP.US undervalued?

Graham number
Price0.3200
Graham value0.3382
Discount5.4%

ELTP.US trades 5.4% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Elite Pharma Inc fundamental analysis

No fundamental analysis for Elite Pharma Inc yet.

Elite Pharma Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Elite Pharma Inc

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. It owns, licenses, manufactures, and sales of generic, oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets, and 15mg and 30mg capsules to treat bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg…

Full company profile